{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03449069",
      "OrgStudyIdInfo": {
        "OrgStudyId": "17-010539"
      },
      "Organization": {
        "OrgFullName": "Mayo Clinic",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Pediatric MSC-AFP Sub-study for Crohn's Fistula",
      "OfficialTitle": "A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 23, 2018",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "February 28, 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 28, 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "February 22, 2018",
      "StudyFirstSubmitQCDate": "February 22, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "February 28, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 29, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 1, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Michael C. Stephens",
        "ResponsiblePartyInvestigatorTitle": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorAffiliation": "Mayo Clinic"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mayo Clinic",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with fistulizing Crohn's disease. Autologous means these cells to coat the plug come from the patient.",
      "DetailedDescription": "The investigators propose to study the safety of autologous mesenchymal stromal cell transfer using a biomatrix (the Gore Bio-A Fistula Plug) in a Phase I study using a single dose of 20 million cells. 5 patients (age 12 to 17 years) with Crohn's perianal fistulas will be enrolled.\n\nSubjects will undergo standard adjuvant therapy including drainage of infection and placement of a draining seton. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore fistula plug as per current clinical practice. The subjects will be subsequently followed for fistula response and closure for 24 months. This is an autologous product derived from the patient and used only for the same patient."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Fistula in Ano",
          "Crohn Disease"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "5",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSC-AFP",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "This is a single treatment group study. All patients will receive treatment of a stem cell coated fistula plug.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: MSC-AFP"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "MSC-AFP",
            "InterventionDescription": "Patients will have a mesenchymal stromal cell coated anal fistula plug placed in their Crohn's perianal fistula tract.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC-AFP"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "mesenchymal stromal cell coated anal fistula plug"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of participants with treatment-related adverse events (safety and toxicity)",
            "PrimaryOutcomeDescription": "Participants will have a health assessment and blood work done at each study visit to monitor for adverse events.",
            "PrimaryOutcomeTimeFrame": "2 months to approximately at 24 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Number of participants with response to the treatment regarding cessation of drainage from the treated fistula.",
            "SecondaryOutcomeDescription": "Participants will have a clinical assessment of fistula drainage at each study visit.",
            "SecondaryOutcomeTimeFrame": "2 months to approximately at 24 months"
          },
          {
            "SecondaryOutcomeMeasure": "Number of participants with radiographic response to the treatment regarding the treated fistula.",
            "SecondaryOutcomeDescription": "Participants will have an assessment of healing radiographically by magnetic resonance imaging (MRI) at Week 2 visit, Week 8, and Week 24.",
            "SecondaryOutcomeTimeFrame": "Week 2, Week 8, and Week 24"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria\n\nMales and females 12-17 years of age.\nResidents of the United States.\nCrohn's disease with single or multiple draining complex perianal fistulae (definition as below) for at least three months despite standard therapy (definition below).\nConcurrent therapies with corticosteroids, 5-aminosalicylate (5-ASA) drugs, thiopurines, methotrexate (MTX), antibiotics, and anti-tumor necrosis factor (TNF) therapy are permitted.\nAll patients should have undergone a colonoscopy in last 12 months to rule out malignant or premalignant condition\nHave no contraindications to MR evaluations: e.g. pacemaker or magnetically active metal fragments, claustrophobia\nAbility to comply with protocol\nCompetent and able to provide written informed consent (and assent where appropriate).\nMust have failed standard medical therapy including anti-TNF agents\n\nExclusion Criteria\n\nInability to obtain informed consent (and assent where appropriate).\nClinically significant medical conditions within the six months before administration of MSCs: e.g. sepsis, pneumonia active serious infection or other conditions that would, in the opinion of the investigators, compromise the safety of the patient.\n\nSpecific exclusions;\n\na. Evidence of hepatitis B, C, or HIV\n\nHistory of cancer including melanoma (with the exception of localized skin cancers)\nInvestigational drug within thirty (30) days of baseline\nA resident outside the United States\nPregnant or trying to become pregnant, or breast feeding.\nHistory of clinically significant auto-immunity (other than Crohn's disease) or any previous example of fat-directed autoimmunity\nPrevious allergic reaction to a perianal fistula plug.\nIf adipose tissue is not technically feasible\nWeight less than 35 kg\nAllergic to local anesthetics\nNon-enterocutaneous tracts (i.e. recto-vaginal, entero-vesicular)",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "12 Years",
      "MaximumAge": "17 Years",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Jessica Friton",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "507-284-0495",
            "CentralContactEMail": "friton.jessica@mayo.edu"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Michael C Stephens",
            "OverallOfficialAffiliation": "Mayo Clinic",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Mayo Clinic in Rochester",
            "LocationStatus": "Recruiting",
            "LocationCity": "Rochester",
            "LocationState": "Minnesota",
            "LocationZip": "55905",
            "LocationCountry": "United States",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Jessica Friton",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "507-284-0495",
                  "LocationContactEMail": "friton.jessica@mayo.edu"
                },
                {
                  "LocationContactName": "Michael C Stephens",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Mayo Clinic Clinical Trials",
            "SeeAlsoLinkURL": "https://www.mayo.edu/research/clinical-trials"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000003424",
            "ConditionMeshTerm": "Crohn Disease"
          },
          {
            "ConditionMeshId": "D000005402",
            "ConditionMeshTerm": "Fistula"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000015212",
            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
          },
          {
            "ConditionAncestorId": "D000005759",
            "ConditionAncestorTerm": "Gastroenteritis"
          },
          {
            "ConditionAncestorId": "D000005767",
            "ConditionAncestorTerm": "Gastrointestinal Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          },
          {
            "ConditionAncestorId": "D000007410",
            "ConditionAncestorTerm": "Intestinal Diseases"
          },
          {
            "ConditionAncestorId": "D000020763",
            "ConditionAncestorTerm": "Pathological Conditions, Anatomical"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M5790",
            "ConditionBrowseLeafName": "Crohn Disease",
            "ConditionBrowseLeafAsFound": "Crohn's Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M7684",
            "ConditionBrowseLeafName": "Fistula",
            "ConditionBrowseLeafAsFound": "Fistula",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9596",
            "ConditionBrowseLeafName": "Intestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M17069",
            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8027",
            "ConditionBrowseLeafName": "Gastroenteritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21672",
            "ConditionBrowseLeafName": "Pathological Conditions, Anatomical",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}